JAMP Pharma Group
Pharmaceutical ManufacturingQuebec, Canada501-1000 Employees
JAMP Pharma Group is a privately owned Canadian pharmaceutical manufacturer with affiliates, headquartered in Boucherville, Quebec. It is a prominent participant in Canada's generic drug sector, with a portfolio of about 345 molecules and ownership of natural health product brands such as Wampole and Laboratoire Suisse, in addition to prescription products from Orimed Pharma. The company operates through a range of functions—including sales, research and development, logistics, quality assurance, regulatory affairs, market access, marketing, business development and export—to deliver quality health products and reliable customer service. Its culture emphasizes performance and collaboration, underpinned by values such as integrity and open communication. Based in the Montreal area, JAMP has sustained steady growth for more than a decade and has expanded its manufacturing footprint in Quebec. In March 2026, the company announced the launch of [Pr] JAMP Enzalutamide as an oral capsule in Canada, expanding access to a prostate cancer therapy.
1-888-653-2347 
support@leadiq.com 
